))
S1 Ep30: Impact of the JAK Inhibitor Approval Delays
Manage episode 389992487 series 3538631
内容由The Cutaneous Connection提供。所有播客内容（包括剧集、图形和播客描述）均由 The Cutaneous Connection 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
This episode takes a deep dive in the recent delay in approval for multiple JAK inhibitor drugs for treatment of inflammatory skin conditions such as psoriasis and atopic dermatitis. Mark Lebwohl, MD, discusses the impact of the delay, as well as the benefits of JAK inhibitors for inflammatory skin diseases, and an outlook for the future of this drug class.
71集单集
分享
